Loading clinical trials...
Loading clinical trials...
The overarching goal of the EPOCH project is to: * Support a broad and robust needs assessment in the haemophilia space in China * Measure the variability in the needs and care provision * Generate o...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Institute of Hematology & Blood Diseases Hospital, China
Collaborators
NCT03961243 · Hemophilia B
NCT06820515 · Hemophilia, Thrombosis, and more
NCT05500807 · Von Willebrand Disease, Type 3, Concomitant VWD and Hemophilia
NCT07101926 · Hemophilia, Rebalancing Agents, and more
NCT06379789 · Hemophilia B
Instiute of Hematology and Blood Diseases Hospital CAMS＆PUMC
Tianjin, Tianjin Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions